Publications by authors named "Shelagh Verco"

Claim this Profile
I
Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies.
Gere S diZerega, Holly A Maulhardt, Shelagh J Verco, Alyson M Marin, Michael J Baltezor

Oncol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome.
Neil R Sharma, Simon K Lo, Andrew Hendifar, Mohamed O Othman, Kalpesh Patel, Shelagh Verco, James Verco

Pancreas· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects: preclinical and clinical studies.
Holly Maulhardt, Shelagh Verco, Michael Baltezor, Alyson Marin, Gere diZerega

Drug Deliv Transl Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early phase trial of intracystic injection of large surface area microparticle paclitaxel for treatment of mucinous pancreatic cysts.
Mohamed Othman, Kalpesh Patel, Somashekar G Krishna, Antonio Mendoza-Ladd, Shelagh Verco, James Verco

Endosc Int Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer.
Max Kates, Ahmed M Mansour, Donald L Lamm, Neal Shore, Holly Maulhardt, James Verco, Shelagh Verco

J Urol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies.
Shelagh Verco, Holly Maulhardt, Michael Baltezor, Emily Williams, Marc Iacobucci, James Verco

Drug Deliv Transl Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NorLeu-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers.
Kathleen E Rodgers, Laura L Bolton, Shelagh Verco, Gere S diZerega

Adv Wound Care (New Rochelle)· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.
Peter P Balingit, David G Armstrong, Alexander M Reyzelman, Laura Bolton, Shelagh J Verco

Wound Repair Regen· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).
Kathleen Rodgers, Shelagh Verco, Laura Bolton, Gere Dizerega

Expert Opin Investig Drugs· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of chemotherapy-induced intraperitoneal adhesion formation in rats by icodextrin at a range of concentrations.
Susan E Conroy, Laura Baines, Kathleen Rodgers, Figen Deviren, Shelagh J Verco

Gynecol Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis